

[ Mon, Nov 12th 2018
] - WOPRAI

[ Fri, Aug 17th 2018
] - WOPRAI

[ Tue, Aug 14th 2018
] - WOPRAI


[ Wed, Feb 28th 2018
] - WOPRAI

[ Mon, Nov 06th 2017
] - WOPRAI

[ Mon, Oct 30th 2017
] - WOPRAI

[ Mon, Oct 16th 2017
] - WOPRAI

[ Mon, Aug 28th 2017
] - WOPRAI

[ Mon, Jul 31st 2017
] - WOPRAI
[ Mon, Jul 31st 2017
] - WOPRAI

[ Wed, Jun 07th 2017
] - WOPRAI
Dewey Steadman Maintained (ANIP) at Strong Buy with Decreased Target to $70 on, Nov 12th, 2018
Dewey Steadman of Canaccord Genuity, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Decreased Target from $75 to $70 on, Nov 12th, 2018.
Dewey has made no other calls on ANIP in the last 4 months.
There is 1 other peer that has a rating on ANIP. Out of the 1 peers that are also analyzing ANIP, 0 agree with Dewey's Rating of Hold.
This is the rating of the analyst that currently disagrees with Dewey
- Brandon Folkes of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $74 on, Wednesday, August 8th, 2018
Similar Top and Current Articles
[ Tue, Oct 23rd 2018
] - WOPRAI
[ Fri, Oct 05th 2018
] - WOPRAI
[ Thu, Sep 13th 2018
] - WOPRAI
[ Thu, Sep 06th 2018
] - WOPRAI
[ Fri, Aug 17th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Wed, Aug 08th 2018
] - WOPRAI
[ Tue, Jun 12th 2018
] - WOPRAI
[ Wed, Feb 28th 2018
] - WOPRAI
[ Fri, Oct 27th 2017
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Nov 02nd 2012
] - WOPRAI